vinorelbine 10 mg/ml concentrate for soln for inf
generics (uk) limited - vinorelbine tartrate - concentrate for soln for inf - 10 mg/ml - vinca alkaloids and analogues
vinorelbine- trima 10 mgml
trima trading (1961), israel - vinorelbine as tartrate - concentrate for solution for infusion - vinorelbine as tartrate 10 mg/ml - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.hormone - refractory prostate cancer, especially in combination with low dose oral corticoid therapy or estramustin.
vinorelbine kabi
fresenius kabi australia pty limited - vinorelbine tartrate -
vinorelbine actavis 10 mgml
devries & co. ltd - vinorelbine as tartrate - concentrate for solution for infusion - vinorelbine as tartrate 10 mg/ml - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer. hormone- refractory prostate cancer, especially in combination with low dose oral corticoid therapy or estramustin.
navelbine
new zealand medical & scientific ltd - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg - soft gelatin capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg excipient: edible ink red ethanol gelatin glycerol anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water titanium dioxide - first line treatment of advanced non-small cell lung cancer (nsclc) as a single agent or in combination
navelbine
new zealand medical & scientific ltd - vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg - soft gelatin capsule - 30 mg - active: vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg excipient: edible ink red ethanol gelatin glycerol anidrisorb 85/70 85% phosal 53 mct iron oxide red macrogol 400 medium-chain triglycerides purified water titanium dioxide - first line treatment of advanced non-small cell lung cancer (nsclc) as a single agent or in combination
vinorelbine teva 10 mg/ml concentrate for soln for inf
teva pharma b.v. - vinorelbine tartrate - concentrate for soln for inf - 10 mg/ml
navelbine oral vinorelbine 80mg (as tartrate) capsule blister pack
pierre fabre australia pty ltd - vinorelbine tartrate, quantity: 110.8 mg (equivalent: vinorelbine, qty 80 mg) - capsule, soft - excipient ingredients: ethanol; purified water; glycerol; macrogol 400; gelatin; iron oxide yellow; titanium dioxide; medium chain triglycerides; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal - non-small cell lung cancer: navelbine oral is indicated for first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,breast cancer: navelbine oral is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
navelbine oral vinorelbine 30mg (as tartrate) capsule blister pack
pierre fabre australia pty ltd - vinorelbine tartrate, quantity: 41.55 mg (equivalent: vinorelbine, qty 30 mg) - capsule, soft - excipient ingredients: ethanol; purified water; glycerol; macrogol 400; gelatin; iron oxide red; titanium dioxide; medium chain triglycerides; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal - non-small cell lung cancer: navelbine oral is indicated for first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,breast cancer: navelbine oral is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.
navelbine oral vinorelbine 20mg (as tartrate) capsule blister pack
pierre fabre australia pty ltd - vinorelbine tartrate, quantity: 27.7 mg (equivalent: vinorelbine, qty 20 mg) - capsule, soft - excipient ingredients: ethanol; purified water; glycerol; macrogol 400; gelatin; iron oxide yellow; titanium dioxide; medium chain triglycerides; ascorbyl palmitate; phosphatidyl choline; dl-alpha-tocopherol; sorbitol; 1,4-sorbitan; mannitol; hydrogenated starch hydrosylate; hypromellose; propylene glycol; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal - non-small cell lung cancer: navelbine oral is indicated for first line treatment of advanced non-small cell lung cancer, as a single agent or in combination.,breast cancer: navelbine oral is indicated for the treatment of advanced breast cancer after failure of standard therapy as a single agent or in combination.